The OTAVA Covalent Inhibitors Library is a meticulously curated collection of small-molecule covalent inhibitors, each designed to form stable, often irreversible, bonds with target proteins. These compounds feature nucleophile-sensitive functional groups that enable precise and selective inhibition, making them powerful tools in modern drug discovery.

Covalent inhibitors are widely recognized for their enhanced potency, prolonged target engagement, and unique therapeutic advantages, particularly in oncology, infectious diseases, neurodegenerative disorders, and enzyme-related conditions. By forming covalent interactions with critical amino acid residues such as cysteine, serine, lysine, and histidine, these compounds provide long-lasting inhibition that can overcome resistance mechanisms and improve drug efficacy.